250 related articles for article (PubMed ID: 22886417)
1. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
Kim KS; Abraham D; Williams B; Violin JD; Mao L; Rockman HA
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1001-10. PubMed ID: 22886417
[TBL] [Abstract][Full Text] [Related]
2. The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.
Monasky MM; Taglieri DM; Henze M; Warren CM; Utter MS; Soergel DG; Violin JD; Solaro RJ
Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H856-66. PubMed ID: 23873795
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.
Abraham DM; Davis RT; Warren CM; Mao L; Wolska BM; Solaro RJ; Rockman HA
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14426-14431. PubMed ID: 27911784
[TBL] [Abstract][Full Text] [Related]
5. Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model.
Tarigopula M; Davis RT; Mungai PT; Ryba DM; Wieczorek DF; Cowan CL; Violin JD; Wolska BM; Solaro RJ
Cardiovasc Res; 2015 Jul; 107(2):226-34. PubMed ID: 26045475
[TBL] [Abstract][Full Text] [Related]
6. Proximal tubule NHE3 activity is inhibited by beta-arrestin-biased angiotensin II type 1 receptor signaling.
Carneiro de Morais CP; Polidoro JZ; Ralph DL; Pessoa TD; Oliveira-Souza M; Barauna VG; Rebouças NA; Malnic G; McDonough AA; Girardi AC
Am J Physiol Cell Physiol; 2015 Oct; 309(8):C541-50. PubMed ID: 26246427
[TBL] [Abstract][Full Text] [Related]
7. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
8. Biased Agonism of the Angiotensin II Type I Receptor.
Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
[TBL] [Abstract][Full Text] [Related]
9.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
10. β-Arrestin-Biased Agonist Targeting the Brain AT
Zanaty M; Seara FAC; Nakagawa P; Deng G; Mathieu NM; Balapattabi K; Karnik SS; Grobe JL; Sigmund CD
Hypertension; 2021 Feb; 77(2):420-431. PubMed ID: 33249862
[TBL] [Abstract][Full Text] [Related]
11. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
Wang J; Hanada K; Gareri C; Rockman HA
J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.
Valdivia Callejon I; Buccioli L; Bastianen J; Schippers J; Verstraeten A; Luyckx I; Peeters S; Danser AHJ; Van Kimmenade RRJ; Meester J; Loeys B
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732244
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.
Boerrigter G; Lark MW; Whalen EJ; Soergel DG; Violin JD; Burnett JC
Circ Heart Fail; 2011 Nov; 4(6):770-8. PubMed ID: 21835984
[TBL] [Abstract][Full Text] [Related]
14. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
[TBL] [Abstract][Full Text] [Related]
15. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
[TBL] [Abstract][Full Text] [Related]
16. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
Teixeira LB; Parreiras-E-Silva LT; Bruder-Nascimento T; Duarte DA; Simões SC; Costa RM; Rodríguez DY; Ferreira PAB; Silva CAA; Abrao EP; Oliveira EB; Bouvier M; Tostes RC; Costa-Neto CM
Sci Rep; 2017 Sep; 7(1):11903. PubMed ID: 28928410
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy.
Ryba DM; Li J; Cowan CL; Russell B; Wolska BM; Solaro RJ
Circulation; 2017 Mar; 135(11):1056-1070. PubMed ID: 28104714
[TBL] [Abstract][Full Text] [Related]
18. Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.
Grisanti LA; Thomas TP; Carter RL; de Lucia C; Gao E; Koch WJ; Benovic JL; Tilley DG
Theranostics; 2018; 8(17):4664-4678. PubMed ID: 30279730
[TBL] [Abstract][Full Text] [Related]
19. Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.
Bathgate-Siryk A; Dabul S; Pandya K; Walklett K; Rengo G; Cannavo A; De Lucia C; Liccardo D; Gao E; Leosco D; Koch WJ; Lymperopoulos A
Hypertension; 2014 Feb; 63(2):404-12. PubMed ID: 24218435
[TBL] [Abstract][Full Text] [Related]
20. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
